Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.20
+3.4%
$1.22
$0.84
$2.03
$45.76M0.99117,014 shs4,439 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
Linde plc stock logo
LIN
Linde
$442.60
-0.3%
$455.83
$350.60
$477.71
$213.15B0.932.20 million shs647,085 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-2.52%+1.75%-2.52%+6.42%-28.40%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
Linde plc stock logo
LIN
Linde
-0.11%-0.58%-5.07%+9.85%+21.60%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
2.0984 of 5 stars
3.50.00.00.01.63.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
Linde plc stock logo
LIN
Linde
3.909 of 5 stars
2.35.02.50.02.62.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00483.33% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
Linde plc stock logo
LIN
Linde
2.54
Moderate Buy$456.793.21% Upside

Current Analyst Ratings

Latest LIN, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Linde plc stock logo
LIN
Linde
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$510.00
4/11/2024
Linde plc stock logo
LIN
Linde
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$480.00 ➝ $540.00
4/10/2024
Linde plc stock logo
LIN
Linde
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$475.00 ➝ $500.00
3/27/2024
Linde plc stock logo
LIN
Linde
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$482.00 ➝ $510.00
3/26/2024
Linde plc stock logo
LIN
Linde
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$503.00 ➝ $510.00
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
3/7/2024
Linde plc stock logo
LIN
Linde
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$434.00 ➝ $503.00
3/1/2024
Linde plc stock logo
LIN
Linde
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoveragePeer Perform
2/16/2024
Linde plc stock logo
LIN
Linde
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform$395.00 ➝ $455.00
2/7/2024
Linde plc stock logo
LIN
Linde
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$470.00 ➝ $480.00
2/7/2024
Linde plc stock logo
LIN
Linde
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$430.00 ➝ $434.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.81N/AN/A$2.97 per share0.40
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
Linde plc stock logo
LIN
Linde
$32.85B6.49$22.20 per share19.94$84.72 per share5.22

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A5/1/2024 (Confirmed)
Linde plc stock logo
LIN
Linde
$6.20B$12.6035.1325.662.9018.87%17.06%8.80%5/2/2024 (Confirmed)

Latest LIN, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Linde plc stock logo
LIN
Linde
$3.68N/A-$3.68N/AN/AN/A  
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million
2/6/202412/31/2023
Linde plc stock logo
LIN
Linde
$3.49$3.59+$0.10$4.02$8.04 billion$8.30 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
Linde plc stock logo
LIN
Linde
$5.561.26%N/A44.13%1 Years

Latest LIN, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/27/2024
Linde plc stock logo
LIN
Linde
quarterly$1.391.2%3/13/20243/14/20243/28/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
Linde plc stock logo
LIN
Linde
0.33
0.80
0.67

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Linde plc stock logo
LIN
Linde
82.80%

Insider Ownership

CompanyInsider Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
28.40%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Linde plc stock logo
LIN
Linde
0.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
Linde plc stock logo
LIN
Linde
66,323481.58 million478.21 millionNot Optionable

LIN, BOLT, CZX, and FCR Headlines

SourceHeadline
Linde Increases Production Capacity and Reduces Emissions in FloridaLinde Increases Production Capacity and Reduces Emissions in Florida
accesswire.com - April 26 at 6:20 AM
Sandhill Capital Partners LLC Decreases Stake in Linde plc (NASDAQ:LIN)Sandhill Capital Partners LLC Decreases Stake in Linde plc (NASDAQ:LIN)
marketbeat.com - April 25 at 8:07 PM
3 Hydrogen Stocks to Buy on the Dip: April 20243 Hydrogen Stocks to Buy on the Dip: April 2024
investorplace.com - April 25 at 6:04 PM
Linde (LIN) Earnings Expected to Grow: What to Know Ahead of Next Weeks ReleaseLinde (LIN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
zacks.com - April 25 at 11:06 AM
2 Hydrogen Stocks To Watch In Late-April 20242 Hydrogen Stocks To Watch In Late-April 2024
stockmarket.com - April 25 at 10:05 AM
Schubert Has “More Tools in Toolbox” With Three CarsSchubert Has “More Tools in Toolbox” With Three Cars
sportscar365.com - April 25 at 8:34 AM
Linde (LIN) Scheduled to Post Earnings on ThursdayLinde (LIN) Scheduled to Post Earnings on Thursday
americanbankingnews.com - April 25 at 2:00 AM
2,820 Shares in Linde plc (NASDAQ:LIN) Purchased by GAMMA Investing LLC2,820 Shares in Linde plc (NASDAQ:LIN) Purchased by GAMMA Investing LLC
marketbeat.com - April 23 at 6:52 PM
Linde inks two deals with China South SteelLinde inks two deals with China South Steel
gasworld.com - April 23 at 4:27 PM
3 Stocks That Look Ready to Rally in a Recovering Market3 Stocks That Look Ready to Rally in a Recovering Market
barrons.com - April 23 at 12:49 PM
BMW Spirits Boosted by Imola PerformanceBMW Spirits Boosted by Imola Performance
sportscar365.com - April 23 at 7:59 AM
GAWDA SMC: Reshoring of US manufacturing spurs industrial gas market growthGAWDA SMC: Reshoring of US manufacturing spurs industrial gas market growth
gasworld.com - April 23 at 7:59 AM
Linde De-captivates Air Separation Unit and Extends Agreement with China South Steel, Member of China Baowu Steel GroupLinde De-captivates Air Separation Unit and Extends Agreement with China South Steel, Member of China Baowu Steel Group
accesswire.com - April 23 at 6:20 AM
HSBCs Asia strategist outlines key reasons for bright investment prospects in IndiaHSBC's Asia strategist outlines key reasons for bright investment prospects in India
cnbctv18.com - April 23 at 2:10 AM
Linde plc (NASDAQ:LIN) Shares Sold by New York State Common Retirement FundLinde plc (NASDAQ:LIN) Shares Sold by New York State Common Retirement Fund
marketbeat.com - April 22 at 9:33 PM
Ardevora Asset Management LLP Sells 42,158 Shares of Linde plc (NASDAQ:LIN)Ardevora Asset Management LLP Sells 42,158 Shares of Linde plc (NASDAQ:LIN)
marketbeat.com - April 21 at 8:44 PM
Linde plc (NASDAQ:LIN) Position Lifted by Sumitomo Mitsui DS Asset Management Company LtdLinde plc (NASDAQ:LIN) Position Lifted by Sumitomo Mitsui DS Asset Management Company Ltd
marketbeat.com - April 20 at 4:59 PM
Linde (NASDAQ:LIN) Rating Increased to Buy at MizuhoLinde (NASDAQ:LIN) Rating Increased to Buy at Mizuho
americanbankingnews.com - April 20 at 6:44 AM
Linde plc to Post Q1 2024 Earnings of $3.66 Per Share, Seaport Res Ptn Forecasts (NASDAQ:LIN)Linde plc to Post Q1 2024 Earnings of $3.66 Per Share, Seaport Res Ptn Forecasts (NASDAQ:LIN)
americanbankingnews.com - April 20 at 1:32 AM
The Hydrogen Stream: Linde plans 5 MW electrolyzer in BrazilThe Hydrogen Stream: Linde plans 5 MW electrolyzer in Brazil
pv-magazine.com - April 19 at 1:47 PM
Andrew Hill Investment Advisors Inc. Takes Position in Linde plc (NASDAQ:LIN)Andrew Hill Investment Advisors Inc. Takes Position in Linde plc (NASDAQ:LIN)
marketbeat.com - April 19 at 12:41 PM
Mizuho Upgrades Linde (LIN)Mizuho Upgrades Linde (LIN)
msn.com - April 19 at 8:47 AM
Seaport Res Ptn Comments on Linde plcs Q1 2024 Earnings (NASDAQ:LIN)Seaport Res Ptn Comments on Linde plc's Q1 2024 Earnings (NASDAQ:LIN)
marketbeat.com - April 19 at 8:17 AM
Brokers Issue Forecasts for Linde plcs Q2 2024 Earnings (NASDAQ:LIN)Brokers Issue Forecasts for Linde plc's Q2 2024 Earnings (NASDAQ:LIN)
americanbankingnews.com - April 19 at 2:16 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
Linde logo

Linde

NASDAQ:LIN
Linde plc operates as an industrial gas company in the Americas, Europe, the Middle East, Africa, Asia, and South Pacific. It offers atmospheric gases, including oxygen, nitrogen, argon, and rare gases; and process gases, such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene. The company also designs and constructs turnkey process plants for third-party customers, as well as for the gas businesses in various locations, such as air separation, hydrogen, synthesis, olefin, and natural gas plants. It serves a range of industries, including healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics. The company was founded in 1879 and is based in Woking, the United Kingdom.